EUVIMEDEUVIMED entdecken
Crossref

Chemotherapy-Induced Neoantigen Nanovaccines Enhance Checkpoint Blockade Cancer Immunotherapy

Guiyuan Chen, Xiangxia Li, Rui Li, Kecheng Wu, Zhouhang Lei, Ruike Dai, Kyle Roche, Andrew Z Wang, Yuanzeng Min iD

ACS Nano · 10.10.2023 · 17 (19) · 18818-18831

DOI: 10.1021/acsnano.3c03274 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 26.09.2023. Verfasst von Guiyuan Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Science and Technology of China, Hefei 230026, China. Hauptthemen laut MEDLINE: Neoplasms, Antineoplastic Agents, Cancer Vaccines. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: University of Science and Technology of China, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapeutics have the potential to increase the efficacy of cancer immunotherapies by stimulating the production of damage-associated molecular patterns (DAMPs) and eliciting mutations that result in the production of neoantigens, thereby increasing the immunogenicity of cancerous lesions. However, the dose-limiting toxicity and limited immunogenicity of chemotherapeutics are not sufficient to induce a robust antitumor response. We hypothesized that cancer cells in vitro treated with ultrahigh doses of various chemotherapeutics artificially increased the abundance, variety, and specificity of DAMPs and neoantigens, thereby improving chemoimmunotherapy. The in vitro chemotherapy-induced (IVCI) nanovaccines manufactured from cell lysates comprised multiple neoantigens and DAMPs, thereby exhibiting comprehensive antigenicity and adjuvanticity. Our IVCI nanovaccines exhibited enhanced immune responses in CT26 tumor-bearing mice, with a significant increase in CD4+/CD8+ T cells in tumors in combination with immune checkpoint inhibitors. The concept of IVCI nanovaccines provides an idea for manufacturing and artificial enhancement of immunogenicity vaccines to improve chemoimmunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsAntineoplastic AgentsCancer VaccinesAnimalsMiceCD8-Positive T-LymphocytesAntigens, NeoplasmImmunotherapy

Stichwörter der Autor:innen

chemotherapyimmune checkpoint inhibitorsimmunogenicityimmunotherapynanovaccine

Substanzen

Antigens, NeoplasmAntineoplastic AgentsCancer Vaccines

Autor:innen und Institutionen

  • Department of Chemistry, University of Science and Technology of China, Hefei 230026, China.
  • School of Medicine and Health Sciences, The George Washington University, Washington D.C. 20052, United States.
  • Department of Radiation Oncology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390, United States.
  • Hefei National Research Center for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei 230026, China.
  • The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230026, China.
  • CAS Key Lab of Soft Matter Chemistry, University of Science and Technology of China, Hefei 230026, China.

ORCID-Profile: Yuanzeng Min

Förderung

  • University of Science and Technology of China
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China

Zitieren

APA

Chen, G., Li, X., Li, R., Wu, K., Lei, Z., Dai, R., Roche, K., Wang, A. Z., & Min, Y. (2023). Chemotherapy-Induced Neoantigen Nanovaccines Enhance Checkpoint Blockade Cancer Immunotherapy. ACS Nano, 17(19), 18818-18831. https://doi.org/10.1021/acsnano.3c03274

Vancouver

Chen G, Li X, Li R, Wu K, Lei Z, Dai R, et al. Chemotherapy-Induced Neoantigen Nanovaccines Enhance Checkpoint Blockade Cancer Immunotherapy. ACS Nano. 2023;17(19):18818-18831. doi:10.1021/acsnano.3c03274

BibTeX
@article{Chen2023,
  author = {Chen, Guiyuan and Li, Xiangxia and Li, Rui and Wu, Kecheng and Lei, Zhouhang and Dai, Ruike and Roche, Kyle and Wang, Andrew Z and Min, Yuanzeng},
  title = {Chemotherapy-Induced Neoantigen Nanovaccines Enhance Checkpoint Blockade Cancer Immunotherapy},
  journal = {ACS Nano},
  year = {2023},
  volume = {17},
  number = {19},
  pages = {18818--18831},
  doi = {10.1021/acsnano.3c03274}
}
Kostenlos starten →